Detalhe da pesquisa
1.
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.
Immunity
; 53(4): 805-823.e15, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053330
2.
Anatomic position determines oncogenic specificity in melanoma.
Nature
; 604(7905): 354-361, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35355015
3.
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Cell
; 150(6): 1135-46, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22980977
4.
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
N Engl J Med
; 388(9): 804-812, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856616
5.
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.
Immunity
; 47(4): 789-802.e9, 2017 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045907
6.
IGFBP7 is not required for B-RAF-induced melanocyte senescence.
Cell
; 141(4): 717-27, 2010 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20478260
7.
Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin.
Nature
; 565(7739): 366-371, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30598548
8.
Author Correction: Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin.
Nature
; 566(7745): E10, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742076
9.
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Lancet Oncol
; 25(4): 509-517, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547894
10.
Cutaneous melanoma.
Lancet
; 402(10400): 485-502, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499671
11.
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.
Ann Oncol
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754780
12.
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Ann Surg Oncol
; 2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38762644
13.
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
Ann Surg Oncol
; 31(3): 1857-1864, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966706
14.
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin
; 67(6): 472-492, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29028110
15.
High response rate to PD-1 blockade in desmoplastic melanomas.
Nature
; 553(7688): 347-350, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320474
16.
Germline variants are associated with increased primary melanoma tumor thickness at diagnosis.
Hum Mol Genet
; 29(21): 3578-3587, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33410475
17.
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Lancet
; 399(10336): 1718-1729, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367007
18.
Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets.
Mod Pathol
; 36(4): 100099, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788083
19.
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach.
J Transl Med
; 21(1): 257, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055772
20.
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes.
J Am Acad Dermatol
; 88(3): 609-616, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509217